
AI patient identification for clinical trials scanning EHRs daily
By Tanmay Verma, Founder · Last verified 03 Jul 2026
In short
HealthKey — AI patient identification for clinical trials scanning EHRs daily. Best for Clinical research sites struggling with enrollment, CROs managing multi-site trials requiring rapid patient identification, Pharmaceutical sponsors with tight timelines for obesity, urology, or oncology trials. Contact Sales pricing.
See what real users actually say. We scan live discussions, reviews and complaints across the web and hand you an honest verdict — in under a minute.
3 free scans · no card needed · downloadable report
HealthKey delivers on its promise of fast, risk-free patient identification for clinical trials, with real case studies showing enrollment gains in weeks. The success-fee model and free setup make it a smart bet for sites, but the lack of transparent pricing and API limits tech-savvy teams. If you need to fill trials fast, it's worth a demo.
Compare with: HealthKey vs Deep 6 AI, HealthKey vs Verge Genomics, HealthKey vs Tempus
Last verified: July 2026
We ran a structured research pass across product reviews, community discussions, and post-purchase forum threads to surface the patterns vendors won't publish themselves. Below: the recurring strengths, the hidden costs people mention most, and the cohort that consistently regrets adopting this tool.
2 mentions across 1 source (Hacker News).
How likely is HealthKey to still be operational in 12 months? Based on 4 signals — momentum (how recently it shipped), wrapper dependency, revenue model, and web presence.
Last calculated: July 2026
How we score →HealthKey is an AI-powered patient identification platform for clinical trials that scans electronic health records daily to surface eligible candidates. Designed for research sites, CROs, and pharmaceutical sponsors, it integrates with existing EHR systems to process thousands of records in minutes, replacing manual chart reviews. The platform works by connecting to the EHR in a HIPAA-compliant manner, encoding trial eligibility criteria with AI, and presenting a curated list of patient matches with supporting evidence. It can process over 80,000 patient records to find exact matches ranked by enrollment likelihood, with case studies showing first enrollment in as little as 25 days for obesity trials and identifying patients missed by other platforms. HealthKey’s key features include automated daily patient matching, custom eligibility criteria encoding, and patient ranking by likelihood to enroll. It supports multiple trial protocols simultaneously and offers a success-fee pricing model with no upfront costs, free implementation, and free protocol setup for up to five trials. Recent deployments span hypertension, bladder cancer, and obesity trials, screening up to 4.6 million records across six sites. The platform emphasizes speed and specificity, with a reported 1-week onboarding timeline. Compared to alternatives, HealthKey’s success-fee model reduces financial risk for sites, and its ability to cross-reference entire EHRs daily can catch patients that periodic manual or other automated approaches miss. However, it lacks a self-service API and transparent public pricing, requiring a sales conversation. For sites focused on enrollment volume and diversification, HealthKey is a pragmatic, low-risk entry point.
HealthKey is a solid choice for clinical research sites and CROs that need to boost enrollment without upfront costs. Its success-fee model means you only pay for enrolled patients, with free implementation and protocol setup for up to five trials — a strong value proposition if you have multiple studies running. The platform’s ability to scan entire EHRs daily can uncover patients that periodic manual review or other automated tools miss, as shown in the Access CCT case study where HealthKey found eligible patients another platform didn't. Where HealthKey falls short is for teams that want full control via API or need transparent, self-serve pricing. There’s no public pricing page; you must contact sales. Also, it’s B2B only — patients can’t self-enroll, and very small sites with fewer than 100 patients may not see enough volume to benefit. The platform doesn’t offer a free tier, but the risk-free pricing offsets that. Compared to a tool like TrialScope (which is more sponsor-side and CRM-focused), HealthKey is site-centric, focusing on EHR integration and automated matching. It’s less about managing the full trial lifecycle and more about finding patients. For sites already using another recruitment platform, HealthKey can be a complementary add-on. In practice, the 1-week onboarding and HIPAA compliance are major pluses. The recent case studies provide concrete proof: 323 eligible patients for an obesity trial in 25 days, 23 patients for a Phase 3 GLP-1 trial across six sites, and 1,280 hours saved on a hypertension trial. These numbers back the marketing. If speed is your priority and you don’t need API access, HealthKey is worth a look.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Common stack mates teams adopt alongside HealthKey, with the specific reason each pairing earns its keep.
AI-powered precision neurology platform for faster CNS drug trials
Used HealthKey? Help shape our editorial sentiment research.